For informational and research purposes only. Not medical advice. Content is aggregated from public sources. Always consult a qualified healthcare provider.
Performance & Growth Hormone · Comparison

Ghrelin vs Gonadorelin

A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

GhrelinGonadorelin
CategoryPerformance & Growth HormonePerformance & Growth Hormone
Also known asGHRL, growth hormone-releasing peptide endogenous, ghrelinergic peptide, acyl ghrelinGnRH, gonadotropin-releasing hormone, Factrel, Lutrepulse
EvidenceInvestigational (in trials)Research-stage
Dosing range0.5mcg/kg–2mcg/kg mcg/kg, IV or SC bolus; endogenous levels peak pre-meal50mcg–200mcg mcg, 2–3x per week subcutaneous
AdministrationIntravenous (research), Subcutaneous injectionSubcutaneous injection, Intranasal (pulsatile delivery)
Key side effectsAppetite stimulation, Transient hyperglycemia, Water retention, GH pulse stimulationInjection site reactions, Headache, Nausea, Flushing
Cited sources2 references2 references

Key differences

  • Evidence level differs: Ghrelin is investigational (in trials), while Gonadorelin is research-stage.
  • Administration: Ghrelin — Intravenous (research), Subcutaneous injection; Gonadorelin — Subcutaneous injection, Intranasal (pulsatile delivery).
  • Dosing units differ: Ghrelin is dosed in mcg/kg, Gonadorelin in mcg — they operate at different scales.
  • Frequency: Ghrelin is typically IV or SC bolus; endogenous levels peak pre-meal; Gonadorelin is 2–3x per week subcutaneous.

How each works

Ghrelin

Ghrelin was discovered in 1999 as the endogenous ligand for the GHS-R1a receptor. Its acylated form activates GH release from the pituitary, stimulates appetite via NPY/AgRP hypothalamic neurons, and modulates energy homeostasis and fat storage. The des-acyl form (majority of circulating ghrelin) lacks GHS-R1a activity but has independent cardiovascular and cellular effects.

Gonadorelin

Gonadorelin directly binds GnRH receptors in the anterior pituitary to trigger LH and FSH secretion, which in turn stimulates Leydig cells for testosterone production and maintains spermatogenesis. Used as a TRT adjunct, pulsatile gonadorelin administration mimics natural hypothalamic GnRH to prevent testicular suppression associated with exogenous androgen use.

Read the full Ghrelin profileRead the full Gonadorelin profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.